The Cross-Talk between Canonical and Non-Canonical Wnt-Dependent Pathways Regulates P-Glycoprotein Expression in Human Blood–Brain Barrier Cells

Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma

(2013) Dong-Yan Shen et al.   CANCER SCIENCE

Temozolomide down-regulates P-glycoprotein in human blood–brain barrier cells by disrupting Wnt3 signaling

(2013) Chiara Riganti et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Nanoparticle- and Liposome-carried Drugs: New Strategies for Active Targeting and Drug Delivery Across Blood-brain Barrier

(2013) Martha Pinzon-Daza et al.   CURRENT DRUG METABOLISM

Rho-Kinase Inhibition Improves Ischemic Perfusion Deficit in Hyperlipidemic Mice

(2013) Hwa Kyoung Shin et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/ -catenin pathway

(2013) C. Riganti et al.   NEURO-ONCOLOGY

Protein tyrosine phosphatase 1B modulates GSK3β/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity

(2013) M A Mobasher et al.   Cell Death & Disease

Challenges in drug delivery to tumors of the central nervous system: An overview of pharmacological and surgical considerations

(2012) Laura P. Serwer et al.   ADVANCED DRUG DELIVERY REVIEWS

Mediating Effects of Aryl-Hydrocarbon Receptor and RhoA in Altering Brain Vascular Integrity

(2012) Chih-Cheng Chang et al.   AMERICAN JOURNAL OF PATHOLOGY

Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia

(2012) Stephany Corrêa et al.   BMC CANCER

The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increasesin vitrodrug delivery across blood-brain barrier cells

(2012) ML Pinzón-Daza et al.   BRITISH JOURNAL OF PHARMACOLOGY

PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration

(2012) Jiaojing Liu et al.   CELLULAR SIGNALLING

Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up

(2012) Sagar Agarwal et al.   CURRENT PHARMACEUTICAL DESIGN

Pharmacologic Reduction of Angiographic Vasospasm in Experimental Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis

(2012) Tommaso Zoerle et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells

(2011) Katarzyna D. Kania et al.   BRAIN RESEARCH

Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain

(2011) Sagar Agarwal et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors

(2011) Yasuo Uchida et al.   JOURNAL OF NEUROCHEMISTRY

Involvement of p114-RhoGEF and Lfc in Wnt-3a– and Dishevelled-Induced RhoA Activation and Neurite Retraction in N1E-115 Mouse Neuroblastoma Cells

(2010) Takuji Tsuji et al.   MOLECULAR BIOLOGY OF THE CELL

Small GTPase RhoA and Its Effector Rho Kinase Mediate Oxygen Glucose Deprivation-Evoked In Vitro Cerebral Barrier Dysfunction

(2010) Claire Allen et al.   STROKE

Rho GTPase activity modulates Wnt3a/β-catenin signaling

(2009) Jessica Rossol-Allison et al.   CELLULAR SIGNALLING

Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases

(2009) Bryan T. MacDonald et al.   DEVELOPMENTAL CELL

Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt–β-catenin and Wnt–RhoA–Rac1 pathways

(2009) Vinicio A. de Jesus Perez et al.   JOURNAL OF CELL BIOLOGY

P-Glycoprotein and Breast Cancer Resistance Protein Restrict Apical-to-Basolateral Permeability of Human Brain Endothelium to Amyloid-β

(2009) Leon M Tai et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Fasudil, a Rho-kinase inhibitor, attenuates induction and progression of cerebral aneurysms: Experimental study in rats using vascular corrosion casts

(2009) Hany Eldawoody et al.   NEUROSCIENCE LETTERS

The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway

(2009) M Flahaut et al.   ONCOGENE

RhoA Silencing Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells

(2008) S. Doublier et al.   MOLECULAR CANCER RESEARCH